Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence

被引:28
作者
Omlor, Georg W. [1 ]
Lange, Jessica [1 ]
Streit, Marcus [1 ]
Gantz, Simone [1 ]
Merle, Christian [1 ]
Germann, Thomas [2 ]
Mechtersheimer, Gunhild [3 ]
Fellenberg, Joerg [1 ]
Lehner, Burkhard [1 ]
机构
[1] Heidelberg Univ Hosp, Ctr Orthopaed Trauma Surg & Paraplegiol, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany
[2] Heidelberg Univ, Inst Pathol Heidelberg, D-69120 Heidelberg, Germany
[3] Heidelberg Univ, Dept Diagnost & Intervent Radiol, D-69120 Heidelberg, Germany
关键词
Giant cell tumor; Intralesional resection; Curettage; Bone cement; Hydrogen peroxide; LONG-BONE; SURGICAL-TREATMENT; CURETTAGE; DENOSUMAB; SURGERY; FEMUR;
D O I
10.1186/s12957-019-1613-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundGiant cell tumor of the bone (GCT) has high local recurrence rates and the prognosis is hard to predict. We therefore retrospectively analyzed clinical outcome and recurrences of 51 GCT cases focusing on the effects of adjuvant local use of hydrogen peroxide.MethodsThe series enclosed 51 advanced GCT cases of the upper and lower extremities (n=27 Campanacci grade III; n=24 grade II; n=39 surgery at our institution, n=12 elsewhere). Mean follow-up was 88.3 (62.0) months. Surgical details, histology, metastases, recurrences, and interview-based data on satisfaction and function including the Musculoskeletal Tumor Society (MSTS) score were evaluated. It was investigated whether hydrogen peroxide was additionally used or not to clean the tumor cavity after curettage as we hypothesized influence on recurrences. To analyze the underlying mechanisms, GCT-derived stromal cell lines were cultured in vitro and tested for cell viability and apoptosis after treatment with hydrogen peroxide. Statistical analysis was performed with Student's t tests, analysis of variance (ANOVA) with post hoc testing, Mann-Whitney U tests, chi-square tests, Kaplan-Meier analysis, and multivariate Cox regression analysis.ResultsThe whole series had 21 recurrences (41%). Eleven recurrences were found (28%) after surgery at our institution. Kaplan-Meier analysis of cumulative recurrence-free survival revealed at 2years follow-up 69% (72%, only our institution) and at 10years follow-up 54% (68%, only our institution). Intralesional resection was performed by vigorous curettage, burring, and defect filling with either polymethylmethacrylate bone cement (n=45) or cancellous bone from the iliac crest (n=6). Univariate chi-square analysis showed significantly lower recurrence rate after bone cement filling (2.3-fold, p=0.024). Cleaning of the lesion cavity with hydrogen peroxide significantly reduced recurrence rate (whole collective 2.9-fold, p=0.004; our institution 2.8-fold, p=0.04) and significantly increased cumulative recurrence-free survival rate (whole collective at 10years follow-up 74% versus 31%, p=0.002; our institution 79% versus 48%, p=0.02) compared to cases without hydrogen peroxide treatment. In multivariate analysis, significant risk factors for recurrence were pathological fracture (hazard ratio 3.7; p=0.04), high mitosis rate (hazard ratio 15.6; p=0.01), and lack of hydrogen peroxide use (hazard ratio 6.0; p=0.02). In vitro cell culture analyses found apoptotic nature of hydrogen peroxide induced GCT cell death.Conclusions p id=Par4 The present series proved for the first time that additional cleaning of the tumor cavity with hydrogen peroxide before defect filling significantly reduced recurrence rate and significantly increased recurrence-free survival in advanced but intralesionally treated GCT cases.
引用
收藏
页数:10
相关论文
共 34 条
[1]  
Algawahmed H., 2010, Sarcoma, V2010, P586090, DOI 10.1155/2010/586090
[2]   Giant cell tumor of bone: treatment and outcome of 214 cases [J].
Balke, Maurice ;
Schremper, Laura ;
Gebert, Carsten ;
Ahrens, Helmut ;
Streitbuerger, Arne ;
Koehler, Gabriele ;
Hardes, Jendrik ;
Gosheger, Georg .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (09) :969-978
[3]   Treatment of giant-cell tumors of long bones with curettage and bone-grafting [J].
Blackley, HR ;
Wunder, JS ;
Davis, AM ;
White, LM ;
Kandel, R ;
Bell, RS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (06) :811-820
[4]   GIANT-CELL TUMOR OF BONE [J].
CAMPANACCI, M ;
BALDINI, N ;
BORIANI, S ;
SUDANESE, A .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1987, 69A (01) :106-114
[5]   Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone [J].
Engellau, Jacob ;
Seeger, Leanne ;
Grimer, Robert ;
Henshaw, Robert ;
Gelderblom, Hans ;
Choy, Edwin ;
Chawla, Sant ;
Reichardt, Peter ;
O'Neal, Michael ;
Feng, Amy ;
Jacobs, Ira ;
Roberts, Zachary J. ;
Braun, Ada ;
Bach, Bruce A. .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
[6]  
ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241
[7]   How safe and effective is denosumab for bone giant cell tumour? [J].
Errani, Costantino ;
Tsukamoto, Shinji ;
Mavrogenis, Andreas F. .
INTERNATIONAL ORTHOPAEDICS, 2017, 41 (11) :2397-2400
[8]   Giant cell tumor of the extremity: A review of 349 cases from a single institution [J].
Errani, Costantino ;
Ruggieri, Pietro ;
Nogales Asenzio, Marco Antonio ;
Toscano, Angelo ;
Colangeli, Simone ;
Rimondi, Eugenio ;
Rossi, Giuseppe ;
Longhi, Alessandra ;
Mercuri, Mario .
CANCER TREATMENT REVIEWS, 2010, 36 (01) :1-7
[9]   Overexpression of Inosine 5′-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells [J].
Fellenberg, Joerg ;
Kunz, Pierre ;
Saehr, Heiner ;
Depeweg, Daniela .
PLOS ONE, 2010, 5 (08)
[10]   Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement [J].
Gao, Zhen-hua ;
Yin, Jun-qiang ;
Xie, Xian-biao ;
Zou, Chang-ye ;
Huang, Gang ;
wang, Jin ;
Shen, Jing-nan .
BMC MUSCULOSKELETAL DISORDERS, 2014, 15